Garrett C. Moraski

In vitro activity and comparative efficacy of novel nitrofuran-containing ciprofloxacin analogs against bacterial pathogens including ciprofloxacin-resistant Staphylococcus aureus

Abstract The rapid rise of antimicrobial resistance, especially in Staphylococcus aureus , highlights the urgent need for improved antibacterial agents. In 2019 alone, AMR caused an estimated 1.27 million deaths and contributed to nearly 5 million more globally. Here, we present...